Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Who hasn't sold the day before a stock takes off 🚀🚀
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(91)
•••
Post by jopatcloon Jan 27, 2023 2:03pm
184 Views
Post# 35250626

Who hasn't sold the day before a stock takes off 🚀🚀

Who hasn't sold the day before a stock takes off 🚀🚀
really good
10 demos in 6 months ending Dec 2022 vs 9 demos in first month of 2023. Great growth in demos.
(snowball) sales are coming in $$$ 33 sellers are just a start for a few weeks.
good DD et comment Cardinal for (Duke)

@cardinal The whole sales process as stated by George is very long. However, it ends with the install. They now have many of those install dates scheduled around the world.
@cardinal Duke...
 
@Birddog @Cardinal So my recent convo George stated they did 10 demos last 6 months of 2022 and all resulted in a buying decision (positive), and said so far in 2023 (1/12th of year essentially has passed) we have 9 demos booked (does not sound like any completed as of yet, but booked). Your correspondence seems way more positive than mine.....what am I missing?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities